A thermostable xylanase mutant and its engineering bacteria, preparation and application
Through the directed evolution of Bacillus safflox xylanase, the highly efficient and high-temperature-resistant xylanase mutant G65E/S68N was obtained, which solved the problem of insufficient thermal stability of existing xylanases under high temperature conditions. It improves its efficiency in lignocellulose bioconversion and economical application in industrial applications.
Patent Information
- Application Number
- CN202411132506.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-19
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-08-19
AI Technical Summary
The existing xylanases are insufficient thermal stability under high temperature conditions, which affects their efficiency and economical use in lignocellulose bioconversion.
By directed evolution of Bacillus safflox wild-type xylanase XYN, G65E/S68N mutation was introduced to improve its vitality and thermal stability at 60 °C, and an efficient xylanase mutant G65E/S68N was constructed, and Expression and application in E. coli, Bacillus subtilis, Bacillus amyloligosac and Bacillus licheniformis.
The vitality of the mutant G65E/S68N is increased to 126% of the wild type, and the half-life at 60 °C is extended to 200% of the wild type, which significantly improves the enzymatic efficiency under high temperature conditions and is suitable for degrading lignocellulose and other plant fibers. Plain materials.
Smart Images

Figure CN118652871B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of enzyme genetic engineering, and specifically relates to a thermostable xylanase mutant and an engineering bacterium thereof, as well as preparation and application thereof. Background Art
[0002] The large amount of cellulose, hemicellulose and lignin in straw are abundant renewable resources on the earth. Among them, hemicellulose forms covalent or non-covalent connections with cellulose, lignin and other structures through various branches in the plant cell wall, which plays an important role in maintaining fiber cohesion and cell wall integrity. However, straw is currently generally regarded as waste, causing waste of resources and environmental pollution. If we try to transform it into the energy and bulk chemicals needed for the development of human society, it will be of great significance to alleviate the current problems of energy and resource shortages, environmental pollution and so on.
[0003] At present, there are physical, chemical and biological methods for degrading straw. The physical method can quickly granulate the straw and increase the surface area, which is conducive to the subsequent degradation treatment, but the energy consumption is high, and the straw is only mechanically decomposed, and the cellulose and other difficult-to-degrade parts cannot be effectively converted; pre-treatment of straw by chemical methods, such as acid-base treatment, oxidation treatment, etc., can destroy the structure in the straw and improve the efficiency of subsequent enzymatic hydrolysis, but waste may be generated during the chemical treatment process, there is a risk of environmental pollution, and the treatment conditions need to be strictly controlled; using organisms such as microorganisms or fungi to degrade straw can achieve effective resource conversion and is environmentally friendly, but the biodegradation rate is slow, it takes a certain amount of time to complete the degradation process, and it has high requirements for temperature, pH and other conditions. Therefore, using cellulase to degrade straw is the most common and effective method. However, due to the presence of hemicellulose, the accessibility of cellulase is hindered, resulting in a low degree of saccharification of the straw by the enzyme, so effective degradation of hemicellulose is conducive to the high-value conversion of straw.
[0004] Hemicellulose extracted from different plant sources and plant positions has different microstructures and molecules. The main components of hemicellulose in straw include xylan, mannan and rhamnosyl glycans. The common enzymes that degrade hemicellulose include xylanase, mannanase and rhamnosyl glycanase, among which xylanase (1,4-β-D-xylanase; EC3.2.1.8) is the most important hemicellulose degrading enzyme. The sources of xylanases are very wide, mainly in microorganisms, protozoa, crustaceans and terrestrial plant tissues. Among them, microorganisms are the main source of xylanase. The important xylanase-producing bacteria are mainly Aspergillus, Trichoderma, Penicillium, Streptomyces, Bacillus and rumen cellulosus. In industrial applications, the thermal stability and catalytic activity of enzymes are crucial parameters that directly affect the economic feasibility of enzymes. For example, in processes such as steam explosion and hydrothermal treatment, the substrate is usually in a high temperature state, so enzymatic hydrolysis under high temperature conditions can effectively reduce the cooling time, thereby reducing process costs. In addition, as the temperature increases, the rate of enzymatic reactions also increases, so the development of xylanase with high temperature resistance is of great significance for the bioconversion of lignocellulose. Therefore, it is of great research value to improve the tolerance of xylanase to high temperature through protein engineering.
[0005] Directed evolution of enzyme molecules is a molecular biological method widely used in protein molecular modification. This method does not require knowledge of protein structure, active sites, catalytic mechanism and other information. It artificially creates special evolutionary conditions, simulates natural evolutionary mechanisms, introduces random mutations, and recombines all mutated genes into a mature expression system to generate a gene mutation library, which is then combined with directed screening (or selection) to obtain mutant enzymes with certain expected characteristics. Commonly used methods in directed evolution strategies include: error-prone PCR, DNA shuffling, staggered extension technology and random guided recombination.
[0006] Therefore, in the present invention, by Bacillus Safensis ) were subjected to directed evolution, and xylanase mutants with improved activity and thermal stability were obtained through mutation screening. A xylanase expression system was constructed to construct a high-yield and high-temperature resistant xylanase engineering strain. Summary of the invention
[0007] Based on the requirements of high temperature application scenarios of xylanase, in order to obtain xylanase with improved thermal stability, its existing properties need to be further modified. The purpose of the present invention is to provide a high temperature resistant xylanase mutant.
[0008] The technical solution adopted by the present invention is as follows:
[0009] The safamily of Bacillus safamidis was obtained by molecular biology. Bacillus Safensis) The wild-type xylanase XYN of TCCC 111022 was constructed by enzyme digestion and ligation, and the wild-type xylanase XYN encoding gene was obtained by sequencing. year (The sequence is shown in SEQ ID NO.2). The wild-type XYN gene was randomly mutated using error-prone PCR technology, and the XYN mutant G65E / S68N was screened using the E. coli expression system. The activity of the mutant was increased to 126% of the wild-type XYN, and the half-life at 60°C was increased to 200% of the wild-type XYN. Obtain the coding gene xynm The optimal mutant G65E / S68N was efficiently prepared and applied using Bacillus subtilis WB600, Bacillus amyloliquefaciens CGMCC No.11218 and Bacillus licheniformis.
[0010] One of the technical solutions provided by the present invention is a xylanase mutant, which is obtained by mutation of G65E and S68N on the basis of the wild-type xylanase shown in SEQ ID NO.1, and is named as xylanase mutant G65E / S68N;
[0011] Furthermore, the amino acid sequence of the xylanase mutant G65E / S68N is shown in SEQ ID NO.3;
[0012] Furthermore, the coding gene of the G65E / S68N mutant xynm , the nucleotide sequence is shown in SEQ ID NO.4.
[0013] The second technical solution provided by the present invention is a recombinant plasmid or recombinant strain containing the above mutant encoding gene;
[0014] Furthermore, the expression vector used is pET-28a(+) or pLY-3, and the host is Escherichia coli, Bacillus subtilis, Bacillus amyloliquefaciens or Bacillus licheniformis;
[0015] Furthermore, the host cell is Escherichia coli BL21;
[0016] Furthermore, the host cell is Bacillus subtilis WB600, Bacillus amyloliquefaciens CGMCC No.11218 or Bacillus licheniformis 2709;
[0017] Preferably, the recombinant strain is obtained by connecting the mutant encoding gene to the expression vector pET-28a(+) and expressing it in the host Escherichia coli.
[0018] The third technical solution provided by the present invention is the use of the above-mentioned recombinant plasmid or recombinant strain in producing the xylanase mutant described in the first technical solution.
[0019] The fourth technical solution provided by the present invention is the application of the xylanase mutant described in the first technical solution, especially in the degradation of xylan, or in the synergistic degradation of lignocellulose by cellulase; more particularly, in the degradation of straw, bagasse or bamboo, wherein the straw includes but is not limited to: corn straw, rice straw, wheat straw, etc.
[0020] Beneficial Effects
[0021] The present invention utilizes error-prone PCR technology to mutate the wild-type XYN, and obtains a mutant G65E / S68N whose activity and thermal stability at 60°C are both improved compared with the wild-type. The activity of the mutant is improved to 126% of that of the wild-type XYN, and the half-life at 60°C is improved to 200% of that of the wild-type XYN. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 This is the electrophoresis diagram of PCR amplification of wild-type xylanase, where M is DNA Marker and lane 1 is the xylanase gene year .
[0023] Figure 2 This is a diagram for the verification of enzyme digestion of the recombinant plasmid, where M is a DNA Marker and lane 1 is the recombinant plasmid pET-28a-xyn.
[0024] Figure 3 The curves of enzyme activities of wild-type XYN and mutant G65E / S68N are shown. DETAILED DESCRIPTION
[0025] The technical content of the present invention is further described below in conjunction with the embodiments, but the present invention is not limited to these embodiments, and the protection scope of the present invention cannot be limited by the following embodiments.
[0026] The following definitions are used in the present invention:
[0027] 1. Nomenclature of amino acid and DNA sequences
[0028] The generally accepted IUPAC nomenclature for amino acid residues is used, using the three-letter / one-letter code format. The generally accepted IUPAC nomenclature for DNA nucleic acid sequences is used.
[0029] 2. Identification of xylanase mutants
[0030] The mutated amino acid in the XYN mutant is represented by "original amino acid + position + replaced amino acid". For example, G65E means that the amino acid at position 65 is replaced by Glu from Gly in wild-type XYN; S68N means that the amino acid at position 68 is replaced by Asp from Ser in wild-type XYN; the position number corresponds to the amino acid sequence number of wild-type XYN in SEQ ID NO.1.
[0031] In the present invention, XYN represents wild-type xylanase, G65E / S68N represents xylanase mutant, and lowercase italics year Indicates the gene encoding the wild-type xylanase XYN, in lowercase italics xynm It represents the coding gene of the mutant G65E / S68N. The specific information is shown in the following table.
[0032]
[0033] In the present invention, the amino acid sequence of the wild-type xylanase XYN is shown in SEQ ID NO.1:
[0034] MNLKRLRLLFVVCIGFVLTLTAVPADAKTIYNNEMGTHSGYDYELWKDYGNTSMTLNNNGGAFTAGWNSIGNALFRKGKKFDSTKTHHQLGNISINYNANFNPGGNSYLCVYGWT QSPLAEYYIVDSWGTYRPTGAYKGSFYADGGTYDIYETTRVNQPSIIGIATFKQYWSVRQTKRTSGTVSVSAHFNKWESLGMPMGKMYETAFTVEGYQSSGSANVMTNQLFIGR.
[0035] In the present invention, the amino acid sequence of the mutant G65E / S68N is shown in SEQ ID NO.3:
[0036] MNLKRLRLLFVVCIGFVLTLTAVPADAKTIYNNEMGTHSGYDYELWKDYGNTSMTLNNGGAFTAEWNNIGNALFRKGKKFDSTKTHHQLGNISINYNANFNPGGNSYLCVYGWT QSPLAEYYIVDSWGTYRPTGAYKGSFYADGGTYDIYETTRVNQPSIIGIATFKQYWSVRQTKRTSGTVSVSAHFNKWESLGMPMGKMYETAFTVEGYQSSGSANVMTNQLFIGR.
[0037] The culture medium used in the embodiments of the present invention is as follows:
[0038] LB medium: 5 g / L yeast extract, 10 g / L tryptone, 10.0 g / L NaCl, and the rest is water. For solid medium, add 2% agar.
[0039] Fermentation medium (g / L): 64 corn flour, 40 soybean meal, add 2.7 amylase, 4 Na2HPO4, 0.3 KH2PO4, and the rest is water; keep warm at 90℃ for 30min and then sterilize at 121℃ for 20min.
[0040] The present invention and some solutions of the examples are as follows:
[0041] Wash Buffer (mM): Weigh 29.25 g NaCl, 2.42 g Tris, and 3.5 g imidazole and dissolve them in ultrapure water to make up to 1 L. Filter through a 0.22 µm microporous membrane to remove impurities and store in a refrigerator at 4 ℃ away from light.
[0042] Elution Buffer (mM): Weigh 29.25 g NaCl, 2.42 g Tris, and 13.6 g imidazole and dissolve them in ultrapure water to make up to 1 L. Filter through a 0.22 µm microporous membrane to remove impurities and store in a refrigerator at 4 ℃ away from light.
[0043] Lysis Buffer (mM): Weigh 29.25 g NaCl, 2.42 g Tris, and 1.4 g imidazole and fully dissolve them in ultrapure water. Make up to 1 L. Filter with a 0.22 µm microporous membrane to remove impurities and store in a refrigerator at 4 ℃ away from light.
[0044] 50× electrophoresis buffer: 242 g Tris, 57.1 mL acetic acid, 100 mL 0.5 mol / L EDTA (pH 8.0), and dilute to 1 L with sterile deionized water.
[0045] The present invention will be further explained below through specific examples.
[0046] Example 1: Wild-type xylanase encoding gene year Acquisition
[0047] 1. Use the kit (OMEGA: Bacterial DNA Kit) to extract Bacillus sabiotis ( Bacillus Safensis )TCCC 111022 genomic DNA, extraction steps are as follows:
[0048] (1) Use an inoculation loop to inoculate the strain onto a LB solid plate and culture at 37 °C overnight.
[0049] (2) Pick a single colony from the culture plate and inoculate it into liquid test tube culture medium. Incubate overnight at 37 °C and 220 rpm with shaking.
[0050] (3) Place 3 mL-5 mL of bacterial solution in a sterilized EP tube, centrifuge at 12,000 rpm for 2 min, and discard the supernatant.
[0051] (4) Add 200 μL of sterile water to the EP tube to resuspend the bacteria, then add 50 μL of lysozyme, pipette to mix, and keep at 37 °C for 20 min.
[0052] (5) Add 100 μL BTL buffer and 20 μL proteinase K to the EP tube, vortex to mix, and incubate at 55 °C for 40 min, vortexing to mix every 20 min.
[0053] (6) Add 5 μL of RNase, invert several times to mix, and leave at room temperature for 10 min.
[0054] (7) Centrifuge at 12,000 r / min for 2 min to remove the undigested portion. Transfer the supernatant to a new EP tube, add 220 μL of BDL buffer, and incubate at 65 °C in a water bath for 15 min.
[0055] (8) Add 220 μL of anhydrous ethanol and mix by pipetting.
[0056] (9) Transfer the liquid in the EP tube into the recovery column and let it stand for 1 min. Centrifuge at 12,000 r / min for 1 min. Pour the filtrate back into the recovery column. Repeat twice and discard the waste liquid.
[0057] (10) Add 500 μL HBC buffer, centrifuge at 12,000 rpm for 1 min, and discard the filtrate.
[0058] (11) Add 700 μL DNA wash buffer, let stand for 1 min, centrifuge at 12,000 rpm for 1 min, and discard the filtrate.
[0059] (12) Add 500 μL DNA wash buffer, let stand for 1 min, centrifuge at 12,000 rpm for 1 min, and discard the filtrate.
[0060] (13) Incubate at 12,000 r / min for 2 min, discard the waste liquid tube, and place the recovery column in a new EP tube.
[0061] (14) Dry in a metal bath at 55 °C for 10 min.
[0062] (15) Add 50 μL of 55°C sterile water, let stand at room temperature for 5 min, centrifuge at 12,000 rpm for 2 min, discard the recovery column, and the liquid in the EP tube is the genome.
[0063] 2. Using the extracted genome of Bacillus sabio as a template, a pair of primers were designed upstream and downstream of the ORF frame to introduce restriction enzyme sites respectively. Nco I. Xho I. Xylanase gene of the present invention year The amplification primers are as follows:
[0064] Upstream primer P1: 5'-CATG CCATGG GCAATTTGAAAAGATTGAGGCTTT -3' (the underlined part is Nco I restriction site)
[0065] Downstream primer P2: 5'-CCG CTCGAG TCGTCCAATAAACAGCTGATT -3' (the underlined part is Xho I restriction site)
[0066] P1 and P2 were used as upstream and downstream primers, and the genome of Bacillus saffron was used as a template for amplification.
[0067] The amplification reaction system is:
[0068]
[0069] The amplification program was as follows: 98°C pre-denaturation for 30 s; 98°C denaturation for 10 s, 55°C annealing for 20 s, 72°C extension for 8 s, 30 cycles; 72°C extension for 10 min. The PCR amplification product was subjected to 0.8% agarose gel electrophoresis, and a 687 bp band was obtained ( Figure 1 ), using a small amount of DNA recovery kit to recover the PCR product, and obtain the wild-type xylanase gene of the present invention year (SEQ ID NO.2), using restriction endonuclease Nco I and Xho I pair year The pET-28a plasmid was double digested with enzymes and recovered using a small amount of DNA recovery kit. year Connect with the vector to obtain the recombinant plasmid pET28a- year , enzyme digestion verification Figure 2 As shown, it was transformed into Escherichia coli JM109 and Escherichia coli BL21.
[0070] Example 2 Obtaining the xylanase mutant S68N / G65E
[0071] 1. Error-prone PCR: Using recombinant plasmid pET28a- year Error-prone PCR was performed with 1% β-glutamic acid as the template, and the reaction system was as follows:
[0072]
[0073] Note: The above reagents are from Takara Biotech Co., Ltd.
[0074] After the system is completed, the error-prone PCR reaction is performed, and the program settings are as follows:
[0075] a. Pre-denaturation: 95 ℃ 5 min;
[0076] b. Denaturation: 95 ℃ 30 s;
[0077] c. Annealing: 56 ℃ 45 s;
[0078] d. Extension: 72 °C 90 s;
[0079] EB-D reaction for 35 cycles;
[0080] f. Extension: 72 ℃ 10 min.
[0081] After the PCR reaction was completed, the PCR product was mixed with the vector plasmid Nco I and Xho I double digestion, after purification and recovery, the error-prone PCR product was connected with the vector plasmid pET-28a that had also been double digested, transformed into Escherichia coli BL21, and placed in a 37°C incubator for 12 h to obtain transformants. At the same time, the recombinant plasmid pET28a- year Transformed into E. coli BL21 as a control, named BL21 / pET28a- year .
[0082] 2. Screening method:
[0083] The DNS method (dinitrosalicylic acid method) was used to determine the enzymatic activity of xylanase. Under certain conditions, xylanase can break the glycosidic bonds inside xylan to release reducing sugars. Under alkaline conditions, dinitrosalicylic acid and reducing sugars undergo redox reactions to generate 3-amino-5-nitrosalicylic acid. Under boiling conditions, the product is reddish brown, and within a certain concentration range, the color depth is proportional to the reducing sugar content. The absorbance at 540 nm is measured using an enzyme marker, and the corresponding reducing sugar content is calculated, and then the enzymatic activity of xylanase is calculated.
[0084] The enzyme activity unit (U) of xylanase in the present invention is defined as: with xylan as substrate, under certain conditions (unless otherwise specified, temperature is 60°C, pH is 8.0), the amount of enzyme required to release 1 μmol of reducing sugar per minute is one enzyme activity unit.
[0085] The XYN enzyme activity determination method of the present invention is as follows: 1% (W / V) xylan solution is prepared with 50 mmol / L Na2HPO4-NaH2PO4 buffer (pH 8.0) as substrate, 90 μL of substrate is placed in a 1.5 mL EP tube and kept in a water bath at 60°C for 1 min, then 10 μL of appropriately diluted XYN enzyme solution is added, and the reaction is carried out in a water bath at 60°C for 10 min. After the reaction is completed, 150 μL of DNS reagent is immediately added to the reaction solution and fully mixed and boiled for 5 min for color development. 200 μL is added to a 96-well plate and the absorbance at 540 nm is measured using an enzyme reader.
[0086] XYN activity unit (U / mL) = (x*n) / t*V; x is the xylose concentration (mmol / L); n is the dilution factor of the enzyme solution; t is the reaction time (min); V is the amount of enzyme added in the reaction system (mL).
[0087] 3. Screening of mutant library
[0088] 400 μL of LB liquid medium containing kanamycin (100 μg / mL) was added to each well of a 96-deep-well plate, and a single clone of each transformant was picked and placed in a 96-deep-well plate, and lysozyme was added to break it. The cells were cultured at 160 rpm and 37 °C, and centrifuged (4 °C, 4000 rpm, 10 min). 200 μL was taken to determine the initial activity using the DNS method, and 200 μL was taken to determine the residual enzyme activity using the DNS method after being incubated at 60 °C for 30 min.
[0089] 4. Select mutants with improved enzyme activity.
[0090] Select mutants with improved activity and thermal stability compared to wild-type XYN (i.e., color OD 540 After sequencing, the mutant G65E / S68N (SEQ ID NO.3) and its encoding gene were obtained. xynm (SEQ ID NO.4), save the strain, and xynm The recombinant strain was named BL21 / pET28a- xynm .
[0091] Example 3 Expression and purification of xylanase in Escherichia coli
[0092] (1) Separately express wild-type XYN encoding genes year The recombinant strain BL21 / pET28a- year , and containing xynm The recombinant strain BL21 / pET28a- xynm The plate was streaked with three zones for activation, and a single colony was picked and inoculated into a 5 mL LB liquid test tube with kanamycin resistance added, and cultured at 37 °C with shaking at 220 r / min for 12 h;
[0093] (2) Transfer the inoculum to 250 mL LB liquid medium containing kanamycin resistance at a 2% inoculum volume and culture at 37°C with shaking at 220 rpm for 2-3 h until the OD of the bacterial solution reaches 600 Reach 0.6-0.8;
[0094] (3) Add IPTG inducer for induction (final concentration of 0.5 mmol / L) and culture in a shaker at 110 r / min and 16 °C for 16-20 h;
[0095] (4) Centrifuge the bacterial solution in a 500 mL centrifuge cup at 4°C, 8000 r / min for 10 min to obtain bacterial pellet;
[0096] (5) Resuspend the collected cells in 40 mL of Lysis Buffer (pH 7.0), disrupt them by ultrasonication, and centrifuge to obtain the supernatant.
[0097] (6) The above supernatant was sterile filtered and mixed with Ni 2+ The protein and Ni resin were mixed and stirred at 0-4 °C at 100 r / min on a magnetic stirrer. 2+ The resin binds for 50-70 min and the Ni 2+ The protein solution after resin binding is poured into the purification column, and the impurities are eluted with Wash Buffer;
[0098] (7) Add Elution Buffer for elution. Use an ultrafiltration tube with a pore size of 10 kDa to ultrafilter at 2500×g. When the eluate in the ultrafiltration tube is centrifuged to about 1.5 mL, pour out the filtrate in the collection tube and add 10 mL of Tris-HCl (pH 7.0, 50 mM) to the ultrafiltration tube. Repeat twice. When the supernatant in the ultrafiltration tube is about 1 mL, transfer it to a new EP tube to prepare the pure enzyme solution of wild-type xylanase XYN and the pure enzyme solution of xylanase mutant G65E / S68N, respectively. Determine the protein concentration using a Nanodrop microspectrophotometer and store at 4°C for later use.
[0099] The enzyme activity of the pure enzyme solution was determined. The enzyme activity determination method and reaction system were the same as those in Example 2. The specific activity of the wild-type XYN was 491.3 U / mg; the specific activity of the mutant G65E / S68N was 619.04 U / mg.
[0100] The half-life of the wild-type XYN pure enzyme solution and the mutant G65E / S68N pure enzyme solution at 60°C (pH 8.0) was determined. The wild-type xylanase XYN pure enzyme solution and the xylanase mutant G65E / S68N pure enzyme solution were kept at 60°C (pH 8.0) for a certain period of time, and the DNS method was used to determine the residual enzyme activity of the wild-type XYN and the mutant G65E / S68N. The reaction system was the same as that in Example 2. The enzyme activity change curve is shown in FIG. Figure 3 Finally, the half-lives of the wild type and mutant G65E / S68N at 60°C were calculated to be 18 min and 36 min, respectively.
[0101] Example 4 Expression and preparation of xylanase mutants in Bacillus subtilis
[0102] The gene encoding the xylanase mutant G65E / S68N xynm and wild-type xylanase encoding gene year The new recombinant plasmid pLY-3- xynm and pLY-3- year ;
[0103] The recombinant plasmids were transferred into Bacillus subtilis WB600, and the mutant recombinant bacteria WB600 / pLY-3- xynm and wild-type xylanase recombinant strain WB600 / pLY-3- year .
[0104] The recombinant strain WB600 / pLY-3- xynm, WB600 / pLY-3- year The samples were inoculated into 5 mL of fermentation medium (containing kanamycin, 50 µg / mL) respectively, cultured at 37°C, 220 r / min overnight, transferred to 50 mL of fresh fermentation medium (containing kanamycin, 50 µg / mL) at a 2% inoculum amount, and cultured at 37°C, 220 r / min for 48 h (fermentation medium (g / L): corn flour 64, soybean cake powder 40, 2.7 amylase, Na2HPO44, KH2PO40.3, and the rest was water; kept at 90°C for 30 min and sterilized at 121°C for 20 min).
[0105] The activity of xylanase obtained by fermentation of Bacillus subtilis was determined using the enzyme activity detection method in Example 2 (the fermentation broth was centrifuged and the supernatant was taken to determine the enzyme activity). In Bacillus subtilis, the wild-type enzyme activity was 2368.1 U / mL, and the fermentation enzyme activity of S68N / G65E was 3243.8 U / mL.
[0106] Example 5 Expression and preparation of xylanase mutants in recombinant strains of Bacillus amyloliquefaciens
[0107] The gene encoding the xylanase mutant G65E / S68N xynm and wild-type xylanase encoding gene year The new recombinant plasmid pLY-3- xynm and pLY-3- year ;
[0108] The recombinant plasmids were transferred into Bacillus amyloliquefaciens CGMCC No.11218, and the mutant recombinant bacteria CGMCC No.11218 / pLY-3- xynm and wild-type xylanase recombinant strain CGMCC No.11218 / pLY-3- year .
[0109] The recombinant strain CGMCC No.11218 / pLY-3- xynm 、CGMCC No.11218 / pLY-3- year The samples were inoculated into 5 mL of fermentation medium (containing kanamycin, 50 µg / mL) respectively, cultured at 37°C, 220 r / min overnight, transferred to 50 mL of fresh fermentation medium (containing kanamycin, 50 µg / mL) at a 2% inoculum amount, and cultured at 37°C, 220 r / min for 48 h (fermentation medium (g / L): corn flour 64, soybean cake powder 40, 2.7 amylase, Na2HPO44, KH2PO40.3, and the rest was water; kept at 90°C for 30 min and sterilized at 121°C for 20 min).
[0110] The activity of xylanase obtained by fermentation of Bacillus amyloliquefaciens was determined using the method in Example 2 (the fermentation broth was centrifuged and the supernatant was taken to determine the enzyme activity). The enzyme activity of the wild type of Bacillus amyloliquefaciens was 5119.4 U / mL; the fermentation enzyme activity of the mutant S68N / G65E was 6871.3 U / mL.
[0111] Example 6 Expression and preparation of xylanase mutants in recombinant strains of Bacillus licheniformis
[0112] The gene encoding the xylanase mutant G65E / S68N xynm and wild-type xylanase encoding gene year The new recombinant plasmid pLY-3- xynm and pLY-3- year ;
[0113] The recombinant plasmids were transferred into Bacillus licheniformis 2709, and the mutant recombinant bacteria BL / pLY-3- xynm and wild-type xylanase recombinant strain BL / pLY-3- year .
[0114] The recombinant strain BL / pLY-3- xynm ,BL / pLY-3- year The samples were inoculated into 5 mL of fermentation medium (containing kanamycin, 50 µg / mL) respectively, cultured at 37°C, 220 r / min overnight, transferred to 50 mL of fresh fermentation medium (containing kanamycin, 50 µg / mL) at a 2% inoculum amount, and cultured at 37°C, 220 r / min for 48 h (fermentation medium (g / L): corn flour 64, soybean cake powder 40, 2.7 amylase, Na2HPO44, KH2PO40.3, and the rest was water; kept at 90°C for 30 min and sterilized at 121°C for 20 min).
[0115] The activity of xylanase obtained by fermentation of Bacillus licheniformis was determined by the method in Example 2 (the fermentation broth was centrifuged and the supernatant was taken to determine the enzyme activity). The enzyme activity of the wild type Bacillus licheniformis was 6077.4 U / mL; the enzyme activity of the mutant S68N / G65E was 8227.1 U / mL.
[0116] Example 7 Application of xylanase mutants in degrading straw
[0117] Corn straw, rice straw and wheat straw were used as substrates and cellulase was used as a synergistic catalyst to detect the ability of XYN and its mutant G65E / S68N to degrade different types of straw.
[0118] The reaction system was 1 mL, 20 mmol / L, pH 8.0 sodium phosphate buffer, including 40 mg / mL substrate (substrate corn straw, rice straw, wheat straw treated with 0.4% alkali), 0.02 mg / mL XYN or mutant G65E / S68N, and 0.1 mg / mL commercial cellulase (3 U / mg), with the reaction system without XYN as the control. The reaction was carried out in a 2 mL EP tube, reacted at 60 °C for 1 h, boiled for 10 min to terminate the reaction, and centrifuged at 12,000 r / min for 10 min to obtain the supernatant. The reducing sugar concentration was determined by the dinitrosalicylic acid (DNS) method, that is, 150 μL DNS reagent was added to the reaction solution and mixed thoroughly and boiled for 5 min for color development. 200 μL was added to a 96-well plate and the absorbance at 540 nm was measured using an ELISA reader.
[0119] 1. Saccharification results in corn stover
[0120] Compared with the treatment with cellulase alone, the reducing sugar content in the treatment with mutant G65E / S68N and cellulase was 1.86 times that in the treatment with cellulase alone.
[0121]
[0122] 2. Saccharification results in rice straw
[0123] Compared with the treatment with cellulase alone, the reducing sugar content in the treatment with mutant G65E / S68N and cellulase was 2.11 times that in the treatment with cellulase alone.
[0124]
[0125] 3. Saccharification results in wheat straw
[0126] Compared with the treatment with cellulase alone, the reducing sugar content in the treatment with mutant G65E / S68N and cellulase was 1.82 times that in the treatment with cellulase alone.
[0127]
[0128] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the patent. It should be pointed out that, for those skilled in the art, the above-mentioned embodiments may also be subjected to several deformations, combinations and improvements without departing from the concept of the present patent, and all such improvements and changes shall fall within the scope of protection of the appended claims of the present invention.
Claims
1. A xylanase mutant, characterized in that: The amino acid sequence of the xylanase mutant is shown in SEQ ID NO.
3.
2. A gene encoding the xylanase mutant according to claim 1.
3. The coding gene according to claim 2, characterized in that The nucleotide sequence is shown in SEQ ID NO.
4.
4. A recombinant vector or recombinant strain comprising the coding gene according to claim 2.
5. The recombinant vector according to claim 4, characterized in that The expression vector used was pET-28a (+) or pLY-3.
6. The recombinant strain according to claim 4, characterized in that The host cell used is Bacillus subtilis, Bacillus amyloliquefaciens or Bacillus licheniformis.
7. Use of the recombinant vector or recombinant strain according to claim 4 in producing the xylanase mutant according to claim 1.
8. Use of the xylanase mutant according to claim 1 in degrading xylan.
9. The use according to claim 8, characterized in that It is used in the degradation of straw, bagasse or bamboo.
10. The use according to claim 8, characterized in that It is used in the synergistic cellulase degradation of lignocellulose.
Citation Information
Patent Citations
Heat-resistant xylosidase mutant and preparation thereof
CN115717135A
Preparation with activities of laccase xylanase, peroxidase and its nucleolide series
CN1657611A
